Barclays analyst Alex Scott raised the firm’s price target on Ryan Specialty (RYAN) to $88 from $76 and keeps an Overweight rating on the shares. The firm updated organic growth assumptions for the insurance broker following Q3 earnings and the latest industry pricing data.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty Group Reports Robust Q3 2024 Performance
- Ryan Specialty in final talks to acquire Innovisk Capital
- Ryan Specialty maintains FY24 outlook for organic revenue growth at 13%-14%
- Ryan Specialty reports Q3 adjusted EPS 41c, consensus 42c
- Ryan Specialty price target raised to $84 from $75 at BofA